Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1965 3
1966 2
1967 1
1968 2
1974 2
1977 1
1979 3
1980 1
1983 2
1984 1
1985 4
1986 6
1987 1
1988 2
1989 1
1990 2
1991 1
1992 1
1993 1
1994 1
1995 2
1996 2
1997 1
1998 2
2002 2
2008 5
2009 4
2010 6
2011 4
2012 8
2013 7
2014 14
2015 12
2016 3
2017 3
2018 2
2019 4
2020 3
2021 6
2022 9
2023 7
2024 8
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Results by year

Filters applied: . Clear all
Page 1
Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison.
Pilotto A, Quaresima V, Trasciatti C, Tolassi C, Bertoli D, Mordenti C, Galli A, Rizzardi A, Caratozzolo S, Zancanaro A, Contador J, Hansson O, Palmqvist S, Santis G, Zetterberg H, Blennow K, Brugnoni D, Suárez-Calvet M, Ashton NJ, Padovani A. Pilotto A, et al. Among authors: bertoli d. medRxiv [Preprint]. 2024 May 3:2024.05.02.24306780. doi: 10.1101/2024.05.02.24306780. medRxiv. 2024. Update in: Brain. 2025 Feb 03;148(2):408-415. doi: 10.1093/brain/awae368. PMID: 38746261 Free PMC article. Updated. Preprint.
Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison.
Pilotto A, Quaresima V, Trasciatti C, Tolassi C, Bertoli D, Mordenti C, Galli A, Rizzardi A, Caratozzolo S, Zancanaro A, Contador J, Hansson O, Palmqvist S, De Santis G, Zetterberg H, Blennow K, Brugnoni D, Suárez-Calvet M, Ashton NJ, Padovani A. Pilotto A, et al. Among authors: bertoli d. Brain. 2025 Feb 3;148(2):408-415. doi: 10.1093/brain/awae368. Brain. 2025. PMID: 39679606 Free PMC article.
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E, Shi V, Bransford T, Takeuchi M, Gong J, Lefkowitz M, Packer M, McMurray JJ; Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators. Solomon SD, et al. Lancet. 2012 Oct 20;380(9851):1387-95. doi: 10.1016/S0140-6736(12)61227-6. Epub 2012 Aug 26. Lancet. 2012. PMID: 22932717 Clinical Trial.
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
HPS3/TIMI55–REVEAL Collaborative Group; Bowman L, Hopewell JC, Chen F, Wallendszus K, Stevens W, Collins R, Wiviott SD, Cannon CP, Braunwald E, Sammons E, Landray MJ. HPS3/TIMI55–REVEAL Collaborative Group, et al. N Engl J Med. 2017 Sep 28;377(13):1217-1227. doi: 10.1056/NEJMoa1706444. Epub 2017 Aug 28. N Engl J Med. 2017. PMID: 28847206 Free article. Clinical Trial.
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA.
Quaresima V, Pilotto A, Trasciatti C, Tolassi C, Parigi M, Bertoli D, Mordenti C, Galli A, Rizzardi A, Caratozzolo S, Benussi A, Ashton NJ, Blennow K, Zetterberg H, Giliani S, Brugnoni D, Padovani A. Quaresima V, et al. Among authors: bertoli d. Neurobiol Aging. 2024 Nov;143:30-40. doi: 10.1016/j.neurobiolaging.2024.08.007. Epub 2024 Aug 22. Neurobiol Aging. 2024. PMID: 39208716 Free article.
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
Gurnari C, Pascale MR, Vitale A, Diral E, Tomelleri A, Galossi E, Falconi G, Bruno A, Crisafulli F, Frassi M, Cattaneo C, Bertoli D, Bernardi M, Condorelli A, Morsia E, Poloni A, Crisà E, Caravelli D, Triggianese P, Brussino L, Battipaglia G, Bindoli S, Sfriso P, Caroni F, Dragani M, Mallegni F, Pilo F, Firinu D, Curti A, Papayannidis C, Olivieri A, Kordasti S, Albano F, Pane F, Musto P, Bocchia M, Lugli E, Breccia M, Frigeni M, Dagna L, Greco R, Franceschini F, Campochiaro C, Cantarini L, Voso MT. Gurnari C, et al. Among authors: bertoli d. Am J Hematol. 2024 Feb;99(2):254-262. doi: 10.1002/ajh.27169. Epub 2023 Dec 18. Am J Hematol. 2024. PMID: 38108611 Free article.
LDL-cholesterol levels and lipid lowering therapy in secondary prevention. Baseline data from the BRING-UP prospective registry.
Colivicchi F, Fabbri G, Oliva F, Abrignani MG, Arca M, Averna M, Catapano AL, Ceseri M, Di Fusco SA, Di Lenarda A, Fattirolli F, Gabrielli D, Gonzini L, Gulizia MM, Riccio C, Temporelli PL, Aloia A, Alonzo A, Aschieri D, Barbato E, Bertoli D, Calabrò P, Calò L, Carugo S, Crisci V, La Rosa G, Maffei S, Navazio A, Pavan D, Scelza N, Scicchitano P, Themistoclakis S, Maggioni AP; on the behalf of BRING-UP Prevention. Colivicchi F, et al. Among authors: bertoli d. Int J Cardiol. 2025 Aug 15;433:133290. doi: 10.1016/j.ijcard.2025.133290. Epub 2025 Apr 19. Int J Cardiol. 2025. PMID: 40258403 Free article.
Medical Treatments in Patients With Ambulatory Heart Failure: First Data From the BRING-UP-3 Heart Failure Study.
Oliva F, Orso F, Colivicchi F, Cipriani MG, Dilenarda A, Gabrielli D, Gori M, Gorini M, Iacoviello M, Lucci D, Marini M, Amico F, Bertoli D, Carigi S, D'Elia E, Difusco SA, Fucili A, Lanati G, Menegato A, Moretti M, Navazio A, Passantino A, Pulignano G, Ruzzolini M, Scardovi AB, Somaschini A, Maggioni AP; on the behalf of BRING-UP-3 Heart Failure Investigators. Oliva F, et al. Among authors: bertoli d. J Card Fail. 2025 Mar 20:S1071-9164(25)00144-7. doi: 10.1016/j.cardfail.2025.02.019. Online ahead of print. J Card Fail. 2025. PMID: 40118200 Free article.
147 results